Use of recombinant activated factor VII in intractable bleeding during pediatric neurosurgical procedures

Pediatric Critical Care Medicine

Volumn 8, Issue 6, 2007, Pages 576-579

  Uhrig, Lynn ^a   Blanot, Stéphane ^a   Baugnon, Thomas ^a   Orliaguet, Gilles ^a   Carli, Pierre A ^a   Meyer, Philippe G ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Children; Hemorrhage; Hemostasis; Neurosurgical intensive care; Recombinant activated factor VII

Indexed keywords

APROTININ; BLOOD CLOTTING FACTOR 7; DOPAMINE; FRESH FROZEN PLASMA; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ARTICLE; BLEEDING; BLOOD TRANSFUSION; CASE REPORT; CONTINUOUS INFUSION; DISEASE CONTROL; DRUG EFFECT; FEMALE; HEMORRHAGIC SHOCK; HUMAN; INFANT; INTENSIVE CARE; MALE; NEUROSURGERY; PEDIATRIC SURGERY; PRESCHOOL CHILD; PRIORITY JOURNAL; THROMBOCYTE TRANSFUSION;

EID: 35948999668     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PCC.0000282734.17597.00     Document Type: Article

References (22)

1. Martinowitz U, Kenet G, Segal E, et al: Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma 2001; 51:431-439
2. Hoffman M: A cell-based model of coagulation and the role of factor VIIa. Blood Rev 2003; 17(Suppl 1):S1-S5
3. Hedner U: Recombinant factor VIIa (Novoseven) as a hemostatic agent. Semin Hematol 2001; 38(Suppl 12):43-47
4. Monroe DM, Hoffman M, Oliver JA, et al: Platelet activity of high-dose factor VIIa is independent of tissue factor. Br J Haematol 1997; 99:542-547
5. Martinowitz U, Michaelson M: Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: A report by the Israeli Multidisciplinary rFVIIa Task Force. J Thromb Haemost 2005; 3:640-648
6. Kenet G, Walden R, Eldad A, et al: Treatment of traumatic bleeding with recombinant factor VIIa. Lancet 1999; 354:1879
7. Grounds M: Recombinant factor VIIa (rFVIIa) and its use in severe bleeding in surgery and trauma: A review. Blood Rev 2003; 17(Suppl 1):S11-S21
8. Martinowitz U, Kenet G, Lubetski A, et al: Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma. Can J Anaesth 2002; 49:S15-S20
9. Eikelboom JW, Bird R, Blythe D, et al: Recombinant activated factor VII for the treatment of life-threatening haemorrhage. Blood Coagul Fibrinolysis 2003; 14:713-717
10. Segal S, Shemesh IY, Blumenthal R, et al: Treatment of obstetric hemorrhage with recombinant activated factor VII (rFVIIa). Arch Gynecol Obstet 2003; 268:266-267
11. Segal S, Shemesh IY, Blumental R, et al: The use of recombinant factor VIIa in severe postpartum hemorrhage. Acta Obstet Gynecol Scand 2004; 83:771-772
12. Tobias JD, Simsic JM, Weinstein S, et al: Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients. J Intensive Care Med 2004; 19:270-273
13. Herbertson M: Recombinant activated factor VII in cardiac surgery. Blood Coagul Fibrinolysis 2004; 15(Suppl 1):S31-S32
14. Hartmann M, Sucker C, Messing M: Recombinant activated factor VII in the treatment of near-fatal bleeding during pediatric brain tumor surgery. J Neurosurg 2006; 104:55-58
15. Morenski JD, Tobias JD, Jimenez DF: Recombinant activated factor VII for cerebral injury-induced coagulopathy in pediatric patients: Report of three cases and review of the literature. J Neurosurg 2003; 98:611-616
16. Kessler C: Haemorrhagic complications of thrombocytopenia and oral anticoagulation: Is there a role for recombinant activated factor VII? Intensive Care Med 2002; 28:S228-S234
17. Boffard KD, Riou B, Warren B, et al: Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: Two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 2005; 59:8-18
18. Tobias JD, Groeper K, Berkenbosch JW: Preliminary experience with the use of recombinant factor VIIa to treat coagulation disturbances in pediatric patients. South Med J 2003; 96:12-16
19. Mayer SA, Brun NC, Begtrup K, et al: Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005; 352:777-785
20. Meyer P, Renier D, Arnaud E, et al: Blood loss during repair of craniosynostosis. Br J Anaesth 1993; 71:854-857
21. Basso IN, Keeling D: Myocardial infarction following recombinant activated factor VII in a patient with type 2A von Willebrand disease. Blood Coagul Fibrinolysis 2004; 15:503-504
22. Rosenfeld SB, Watkinson KK, Thompson BH, et al: Pulmonary embolism after sequential use of recombinant factor VIIa and activated prothrombin complex concentrate in a factor VIII inhibitor patient. Thromb Haemost 2002; 87:925-926